We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
-14.24%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$293M
AUM Growth
-$43.2M
Cap. Flow
+$11.1M
Cap. Flow %
3.81%
Top 10 Hldgs %
35.3%
Holding
250
New
19
Increased
89
Reduced
74
Closed
21

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.91M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.75M
3
LHX icon
L3Harris
LHX
+$2.62M
4
OXY icon
Occidental Petroleum
OXY
+$2.25M
5
WSO icon
Watsco Inc
WSO
+$1.83M

Sector Composition

Rank Sector Weight
1 Financials 15.77%
2 Healthcare 14.17%
3 Energy 10.64%
4 Industrials 9.87%
5 Communication Services 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.1T
$40.2M 13.73%
147,211
+11,965
+9% +$3.75M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.36T
$11.1M 3.8%
104,640
+12,960
+14% +$1.53M
EPD icon
3
Enterprise Products Partners
EPD
$82.3B
$11.1M 3.78%
454,595
+32,515
+8% +$855K
AWK icon
4
American Water Works
AWK
$26.7B
$7.94M 2.71%
53,354
+5,187
+11% +$790K
IFF icon
5
International Flavors & Fragrances
IFF
$20.2B
$6.82M 2.33%
57,224
+134
+0.2% +$16.7K
HEI icon
6
HEICO Corp
HEI
$49.8B
$5.95M 2.03%
45,370
-140
-0.3% -$19.7K
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$5.24M 1.79%
8,866
-20
-0.2% -$13K
AAPL icon
8
Apple
AAPL
$4.54T
$5.17M 1.76%
37,788
-842
-2% -$128K
NVO
9
Novo Nordisk
NVO
$208B
$5.14M 1.75%
92,236
+12
+0% +$666
BCPC
10
Balchem Corp
BCPC
$5.38B
$4.71M 1.61%
36,332
+4,382
+14% +$548K
WTRG icon
11
Essential Utilities
WTRG
$11.3B
$4.38M 1.49%
95,448
-514
-0.5% -$23.9K
NOC icon
12
Northrop Grumman
NOC
$77.1B
$4.05M 1.38%
8,465
-148
-2% -$68K
GMAB icon
13
Genmab
GMAB
$17.7B
$3.9M 1.33%
119,956
+275
+0.2% +$8.91K
MKC icon
14
McCormick & Company Non-Voting
MKC
$13.7B
$3.78M 1.29%
45,363
-97
-0.2% -$9.19K
MDT icon
15
Medtronic
MDT
$109B
$3.73M 1.27%
41,517
+1,549
+4% +$157K
CYXT
16
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$3.63M 1.24%
320,486
+6,795
+2% +$87.6K
MP icon
17
MP Materials
MP
$7.36B
$3.6M 1.23%
112,264
-100
-0.1% -$4.04K
LIN icon
18
Linde
LIN
$221B
$3.6M 1.23%
+12,505
New +$3.91M
INGR icon
19
Ingredion
INGR
$6.27B
$3.51M 1.2%
39,823
-1,289
-3% -$115K
PEP icon
20
PepsiCo
PEP
$190B
$3.5M 1.2%
21,033
-1,615
-7% -$272K
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$121B
$3.48M 1.19%
12,333
-935
-7% -$250K
DEO icon
22
Diageo
DEO
$49B
$3.47M 1.19%
19,940
-122
-0.6% -$23.2K
ZBRA icon
23
Zebra Technologies
ZBRA
$14B
$3.41M 1.16%
11,602
+4,217
+57% +$1.47M
KMI icon
24
Kinder Morgan
KMI
$71.7B
$3.39M 1.16%
202,364
-11,632
-5% -$218K
CVX icon
25
Chevron
CVX
$392B
$3.38M 1.15%
23,346
-839
-3% -$139K

Similar funds

Cutter & Co Brokerage's Q2 2022 Portfolio in Review

As of Q2 2022, Cutter & Co Brokerage held 250 positions worth $293M, down 13% from $336M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Cutter & Co Brokerage deployed $11.1M of net new capital in Q2 2022, opening 19 new positions and adding to 89 existing holdings. Its largest new stake was Linde: 12,505 shares worth $3.6M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $2.2M trimmed.

  • Cutter & Co Brokerage's largest Q2 2022 buy was Linde: 12,505 shares worth $3.6M.
  • Cutter & Co Brokerage added most to Berkshire Hathaway Class B in Q2 2022, an estimated $3.75M increase.
  • Cutter & Co Brokerage's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $2.2M.
  • Cutter & Co Brokerage fully exited Sensient Technologies in Q2 2022, selling an estimated $4.35M.
  • Cutter & Co Brokerage's ten largest holdings make up 35% of its $293M portfolio in Q2 2022.
  • Cutter & Co Brokerage opened 19 new positions and closed 21 in Q2 2022.
  • Cutter & Co Brokerage's portfolio value fell 13% quarter-over-quarter to $293M.

Based on Cutter & Co Brokerage's 13F filing for Q2 2022, filed 28 Jul 2022.